Skip to content
Disclosery

Parkman Healthcare Partners LLC

Follow

13F filer, CIK 1777015, STAMFORD, CT

Parkman Healthcare Partners LLC reported $958,704,189 across 91 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 31.93% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-003321

Period
2025-09-30
Reported value
$959M
Holdings
91
Top 10 weight
31.93%
New
15
Sold out
12

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BIIBnew+130,165$18.2M
BSXadded+151,211$14.8M
KALVadded+1,055,940$12.9M
MCKadded+11,084$8.56M
FOLDadded+1,078,681$8.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
THCreduced-94,554-$19.2M
VERONA PHARMA PLCexited-197,898-$18.7M
LLYreduced-23,296-$17.8M
RVTYexited-157,196-$15.2M
IQVreduced-79,500-$15.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001420506-25-003321, largest first. % of portfolio is the value over $910,674,589, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 447,196 shares; 2024Q4: 337,354 shares; 2025Q1: 225,990 shares; 2025Q2: 283,166 shares; 2025Q3: 434,377 shares 434,377$42.4M4.66%+151,211Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,485 shares; 2024Q4: 38,672 shares; 2025Q1: 68,938 shares; 2025Q2: 92,338 shares; 2025Q3: 87,690 shares 87,690$40M4.39%-4,648Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 159,689 shares; 2024Q4: 125,761 shares; 2025Q1: 130,514 shares; 2025Q2: 105,762 shares; 2025Q3: 116,238 shares 116,238$35.9M3.94%+10,476Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 180,000 shares; 2025Q1: 496,736 shares; 2025Q2: 517,807 shares; 2025Q3: 379,486 shares 379,486$28.6M3.14%-138,321Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 755,244 shares; 2024Q4: 765,453 shares; 2025Q1: 762,621 shares; 2025Q2: 488,796 shares; 2025Q3: 671,592 shares 671,592$26.1M2.86%+182,796Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 425,000 shares; 2024Q4: 1,087,634 shares; 2025Q1: 1,064,506 shares; 2025Q2: 1,298,825 shares; 2025Q3: 1,154,487 shares 1,154,487$24.9M2.74%-144,338Timeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,500 shares; 2025Q2: 240,395 shares; 2025Q3: 251,420 shares 251,420$24.8M2.72%+11,025Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: 77,717 shares; 2025Q1: 77,690 shares; 2025Q2: 50,376 shares; 2025Q3: 64,108 shares 64,108$23.7M2.6%+13,732Timeline
QIAGEN N.V.QIAGEN N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 359,644 shares; 2025Q2: 498,107 shares; 2025Q3: 500,159 shares 500,159$22.3M2.45%+2,052
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,000 shares; 2025Q1: 22,101 shares; 2025Q2: 17,458 shares; 2025Q3: 28,542 shares 28,542$22M2.42%+11,084Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 63,250 shares; 2025Q2: 110,090 shares; 2025Q3: 110,541 shares 110,541$21.9M2.41%+451Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 753,752 shares; 2025Q2: 679,063 shares; 2025Q3: 1,735,003 shares 1,735,003$21.1M2.32%+1,055,940Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 275,000 shares; 2025Q1: 203,833 shares; 2025Q2: 443,422 shares; 2025Q3: 345,356 shares 345,356$20.2M2.21%-98,066Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,840 shares; 2024Q4: 115,727 shares; 2025Q1: 168,382 shares; 2025Q2: 166,010 shares; 2025Q3: 141,822 shares 141,822$19.9M2.19%-24,188Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,165 shares 130,165$18.2M2%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 293,928 shares; 2025Q2: 463,601 shares; 2025Q3: 455,523 shares 455,523$17.3M1.9%-8,078Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 233,563 shares; 2025Q2: 715,504 shares; 2025Q3: 843,502 shares 843,502$15.9M1.74%+127,998Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,753 shares; 2024Q4: 106,987 shares; 2025Q1: 213,418 shares; 2025Q2: 168,884 shares; 2025Q3: 74,330 shares 74,330$15.1M1.66%-94,554Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,393 shares; 2024Q4: 578,511 shares; 2025Q1: 1,780,454 shares; 2025Q2: 2,107,483 shares; 2025Q3: 1,791,674 shares 1,791,674$14.6M1.6%-315,809Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,729 shares; 2024Q4: 174,934 shares; 2025Q1: 166,871 shares; 2025Q2: 175,000 shares; 2025Q3: 275,811 shares 275,811$14.4M1.59%+100,811Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 170,000 shares; 2025Q1: 328,323 shares; 2025Q2: 871,933 shares; 2025Q3: 773,304 shares 773,304$13.5M1.49%-98,629Timeline
FOLDAMICUS THERAPEUTICQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 605,318 shares; 2024Q4: 784,376 shares; 2025Q1: 568,952 shares; 2025Q2: 608,637 shares; 2025Q3: 1,687,318 shares 1,687,318$13.3M1.46%+1,078,681Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 93,500 shares; 2025Q2: 120,834 shares; 2025Q3: 178,970 shares 178,970$13.1M1.44%+58,136Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 508,283 shares; 2024Q4: 526,973 shares; 2025Q1: 594,987 shares; 2025Q2: 867,813 shares; 2025Q3: 846,899 shares 846,899$13M1.43%-20,914Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 177,368 shares; 2025Q1: 280,314 shares; 2025Q2: 181,643 shares; 2025Q3: 202,363 shares 202,363$12.4M1.36%+20,720Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,492 shares; 2024Q4: 44,492 shares; 2025Q1: 67,390 shares; 2025Q2: 174,276 shares; 2025Q3: 149,848 shares 149,848$12.3M1.35%-24,428Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 145,214 shares; 2025Q1: 200,819 shares; 2025Q2: 251,741 shares; 2025Q3: 155,766 shares 155,766$12.1M1.33%-95,975Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 292,593 shares; 2024Q4: 274,569 shares; 2025Q1: 312,650 shares; 2025Q2: 385,479 shares; 2025Q3: 176,523 shares 176,523$12.1M1.33%-208,956Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 306,027 shares 306,027$11.6M1.27%+166,027Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,588 shares; 2024Q4: 78,550 shares; 2025Q1: 130,367 shares; 2025Q2: 225,875 shares; 2025Q3: 171,628 shares 171,628$11.5M1.27%-54,247Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 296,071 shares; 2024Q4: 304,629 shares; 2025Q1: 350,551 shares; 2025Q2: 352,262 shares; 2025Q3: 475,568 shares 475,568$10.8M1.19%+123,306Timeline
OPRXOPTIMIZERX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 475,000 shares; 2025Q2: 507,423 shares; 2025Q3: 509,611 shares 509,611$10.4M1.15%+2,188Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,400 shares; 2024Q4: 23,588 shares; 2025Q1: 109,988 shares; 2025Q2: 119,623 shares; 2025Q3: 120,190 shares 120,190$10.4M1.14%+567Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 396,336 shares; 2024Q4: 228,334 shares; 2025Q1: 446,106 shares; 2025Q2: 648,871 shares; 2025Q3: 696,980 shares 696,980$10.1M1.11%+48,109Timeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 111,652 shares; 2025Q2: 192,705 shares; 2025Q3: 221,044 shares 221,044$9.36M1.03%+28,339Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,031 shares; 2024Q4: 37,472 shares; 2025Q1: 10,232 shares; 2025Q2: 8,811 shares; 2025Q3: 22,000 shares 22,000$9.22M1.01%+13,189Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 412,888 shares; 2024Q4: 365,703 shares; 2025Q1: 536,832 shares; 2025Q2: 674,551 shares; 2025Q3: 501,832 shares 501,832$8.95M0.98%-172,719Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 657,070 shares; 2024Q4: 381,173 shares; 2025Q1: 425,407 shares; 2025Q2: 647,331 shares; 2025Q3: 550,173 shares 550,173$8.92M0.98%-97,158Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,025,754 shares; 2024Q4: 1,273,789 shares; 2025Q1: 1,215,629 shares; 2025Q2: 599,610 shares; 2025Q3: 652,680 shares 652,680$8.88M0.97%+53,070Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 75,000 shares; 2025Q3: 100,442 shares 100,442$8.52M0.94%+25,442Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,086,067 shares; 2024Q4: 1,117,792 shares; 2025Q1: 954,071 shares; 2025Q2: 827,060 shares; 2025Q3: 339,764 shares 339,764$8.12M0.89%-487,296Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 347,541 shares; 2024Q4: 369,861 shares; 2025Q1: 393,153 shares; 2025Q2: 176,702 shares; 2025Q3: 402,595 shares 402,595$8.03M0.88%+225,893Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 42,108 shares; 2025Q3: 40,343 shares 40,343$8.02M0.88%-1,765Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 650,000 shares; 2025Q3: 579,174 shares 579,174$7.87M0.86%-70,826Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 464,048 shares; 2024Q4: 216,881 shares; 2025Q1: 1,000,562 shares; 2025Q2: 1,007,992 shares; 2025Q3: 1,012,664 shares 1,012,664$7.69M0.84%+4,672Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,260 shares; 2024Q4: 100,301 shares; 2025Q1: 166,278 shares; 2025Q2: 220,387 shares; 2025Q3: 223,065 shares 223,065$7.66M0.84%+2,678Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,384 shares; 2024Q4: 28,163 shares; 2025Q1: 39,191 shares; 2025Q2: 33,296 shares; 2025Q3: 10,000 shares 10,000$7.63M0.84%-23,296Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,000 shares; 2024Q4: 175,415 shares; 2025Q1: 183,678 shares; 2025Q2: 386,646 shares; 2025Q3: 252,817 shares 252,817$7.45M0.82%-133,829Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 191,658 shares; 2024Q4: 193,004 shares; 2025Q1: 174,576 shares; 2025Q2: 150,373 shares; 2025Q3: 176,137 shares 176,137$7.07M0.78%+25,764Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 545,751 shares; 2024Q4: 829,105 shares; 2025Q1: 959,703 shares; 2025Q2: 817,808 shares; 2025Q3: 934,760 shares 934,760$7.02M0.77%+116,952Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,191,343 shares; 2025Q2: 1,542,823 shares; 2025Q3: 2,101,715 shares 2,101,715$6.91M0.76%+558,892Timeline
SDGRSCHRODINGER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 559,105 shares; 2024Q4: 563,091 shares; 2025Q1: 481,470 shares; 2025Q2: 587,556 shares; 2025Q3: 340,187 shares 340,187$6.82M0.75%-247,369Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 277,252 shares; 2025Q2: 225,150 shares; 2025Q3: 125,949 shares 125,949$6.82M0.75%-99,201Timeline
CERTCERTARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 551,850 shares 551,850$6.74M0.74%+51,850Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,981 shares 250,981$6.43M0.71%newTimeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 231,099 shares; 2025Q2: 549,052 shares; 2025Q3: 454,512 shares 454,512$6.42M0.7%-94,540Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 104,081 shares; 2024Q4: 854,716 shares; 2025Q1: 1,171,416 shares; 2025Q2: 1,235,305 shares; 2025Q3: 2,440,633 shares 2,440,633$5.88M0.65%+1,205,328Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares 250,000$5.88M0.65%newTimeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 109,500 shares; 2025Q3: 30,000 shares 30,000$5.7M0.63%-79,500Timeline
TMCITREACE MED CONCEPTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 713,539 shares; 2025Q2: 843,998 shares; 2025Q3: 847,675 shares 847,675$5.69M0.62%+3,677Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,316 shares; 2024Q4: 216,600 shares; 2025Q1: 231,109 shares; 2025Q2: 362,008 shares; 2025Q3: 378,583 shares 378,583$5.57M0.61%+16,575Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares 200,000$5.19M0.57%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 175,000 shares; 2025Q3: 45,250 shares 45,250$4.88M0.54%-129,750Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 55,197 shares 55,197$4.69M0.51%newTimeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 85,000 shares; 2025Q1: 46,663 shares; 2025Q2: 55,404 shares; 2025Q3: 105,831 shares 105,831$4.2M0.46%+50,427Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 351,131 shares 351,131$4.11M0.45%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 61,596 shares; 2025Q3: 61,849 shares 61,849$4.11M0.45%+253Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 285,099 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,380 shares 100,380$4.03M0.44%newTimeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 682,897 shares; 2024Q4: 921,174 shares; 2025Q1: 1,229,522 shares; 2025Q2: 789,099 shares; 2025Q3: 491,408 shares 491,408$3.97M0.44%-297,691Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,304,085 shares; 2024Q4: 3,126,727 shares; 2025Q1: 2,493,836 shares; 2025Q2: 1,900,918 shares; 2025Q3: 656,084 shares 656,084$3.52M0.39%-1,244,834Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,320 shares; 2024Q4: 300,698 shares; 2025Q1: 631,238 shares; 2025Q2: 633,874 shares; 2025Q3: 380,713 shares 380,713$3.42M0.38%-253,161Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,753 shares 200,753$3.36M0.37%newTimeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 77,623 shares; 2024Q4: 51,133 shares; 2025Q1: 63,940 shares; 2025Q2: 73,412 shares; 2025Q3: 73,725 shares 73,725$3.07M0.34%+313Timeline
RPIDRAPID MICRO BIOSYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 735,621 shares; 2025Q2: 913,443 shares; 2025Q3: 913,443 shares 913,443$3.05M0.34%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 76,125 shares; 2025Q2: 116,343 shares; 2025Q3: 96,737 shares 96,737$2.81M0.31%-19,606Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 219,451 shares; 2024Q4: 220,980 shares; 2025Q1: 234,784 shares; 2025Q2: 270,131 shares; 2025Q3: 271,306 shares 271,306$2.69M0.3%+1,175Timeline
TVRDTVARDI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 65,000 shares 65,000$2.53M0.28%newTimeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 396,396 shares 396,396$2.45M0.27%newTimeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 924,140 shares; 2024Q4: 1,000,474 shares; 2025Q1: 1,043,162 shares; 2025Q2: 500,000 shares; 2025Q3: 301,746 shares 301,746$2.13M0.23%-198,254Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 109,468 shares; 2024Q4: 100,159 shares; 2025Q1: 304,244 shares; 2025Q2: 147,980 shares; 2025Q3: 68,636 shares 68,636$2.06M0.23%-79,344Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares 200,000$1.74M0.19%newTimeline
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 515,992 shares; 2025Q3: 252,211 shares 252,211$1.37M0.15%-263,781Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 328,613 shares; 2024Q4: 330,849 shares; 2025Q1: 351,436 shares; 2025Q2: 404,194 shares; 2025Q3: 405,953 shares 405,953$1.24M0.14%+1,759Timeline
BFLYBUTTERFLY NETWORK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 750,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 602,192 shares 602,192$1.16M0.13%newTimeline
MASS908 DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares; 2025Q3: 100,368 shares 100,368$879K0.1%+368Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 206,444 shares; 2024Q4: 207,853 shares; 2025Q1: 611,875 shares; 2025Q2: 605,029 shares; 2025Q3: 500,662 shares 500,662$811K0.09%-104,367Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares 100,000$573K0.06%newTimeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 411,076 shares; 2024Q4: 413,732 shares; 2025Q1: 439,632 shares; 2025Q2: 355,822 shares; 2025Q3: 280,822 shares 280,822$539K0.06%-75,000Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,832 shares; 2024Q4: 154,832 shares; 2025Q1: 154,832 shares; 2025Q2: 154,832 shares; 2025Q3: 154,832 shares 154,832$355K0.04%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,978 shares 202,978$264K0.03%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput80,000$48Mnew

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VERONA PHARMA PLCVERONA PHARMA PLC197,898$18.7Mshares
RVTYREVVITY INC157,196$15.2Mshares
GILDGILEAD SCIENCES INC131,675$14.6Mshares
MERUS N VMERUS N V162,980$8.57Mshares
ANIPANI PHARMACEUTICALS INC128,478$8.38Mshares
REPLREPLIMUNE GROUP INC896,710$8.33Mshares
DGXQUEST DIAGNOSTICS INC40,997$7.36Mshares
ALKSALKERMES PLC200,000$5.72Mput
PERFORMANT HEALTHCARE INCPERFORMANT HEALTHCARE INC1,214,272$4.86Mshares
NRIXNURIX THERAPEUTICS INC228,271$2.6Mshares
ARDXARDELYX INC301,086$1.18Mshares
ATYRATYR PHARMA INC150,000$760Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-003321 base2025-11-14acceptance time not in the bulk data set